FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine. What is described is a pharmaceutical composition containing licarbazepine acetate, preferentially eslicarbazepine acetate, in a combination with acceptable excipients, particularly a binding agent and a disintegrating agent. What is also described is a method for wet granulation for preparing the pharmaceutical composition.
EFFECT: composition is compacted as a tablet, which has reduced size and volume density.
79 cl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TABLETS OF ULIPRISTAL ACETATE | 2009 |
|
RU2492853C2 |
| PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2316324C2 |
| PHARMACEUTICAL PREPARATIONS CONTAINING NITRO CATECHINE DERIVATIVES, AND METHODS FOR PREPARING THEREOF | 2010 |
|
RU2701731C2 |
| DOSAGE FORM CONTAINING DESLORATADINE AND METHOD FOR PRODUCING IT | 2013 |
|
RU2550958C2 |
| PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION WITH MASKED TASTE AND PREPARATION METHOD THEREOF | 2012 |
|
RU2583935C2 |
| ESLICARBAZEPINE ACETATE AND METHODS FOR APPLYING THEREOF | 2005 |
|
RU2417085C2 |
| NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
| PHARMACEUTICAL COMPOSITION IN FORM OF SINGLE ORAL DOSE CONTAINING LEVODOPA, CARBIDOPA AND ENTACAPONE, OR SALTS THEREOF | 2009 |
|
RU2519159C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ALEGLITEZAR | 2010 |
|
RU2537224C2 |
| TREATMENT USING ESLICARBAZEPINE ACETATE OR ESLICARBAZEPINE | 2012 |
|
RU2639120C2 |
